氨氯地平阿托伐他汀钙片治疗高血压合并冠心病的分析

Analysis of the amlodipine atorvastatin calcium tablets in treatment of hypertension with coronary heart disease

选择高血压合并冠心病患者共106例,均为我院就诊,时间为2016年5月12日—2017年5月12日,分别给予不同药物进行治疗,将两组治疗效果进行综合分析。血压水平:治疗前两组的血压无明显差异,P>0.05,治疗后实验组的血压水平明显低于常规组,P<0.05;治疗总有效率:实验组为94.34%,常规组为81.13%,P<0.05;实验组治疗后的血脂指标水平均明显低于常规组,P<0.05。说明对高血压合并冠心病患者给予氨氯地平阿托伐他汀钙片,治疗效果显著,值得采纳。

A total of 106 patients with hypertension complicated with coronary heart disease were selected. All of them were hospitalized in our hospital from May 2016 to May 2017. Different drugs were given for treatment and the effects of two groups were comprehensively analyzed. Blood pressure level： There was no significant difference in blood pressure between two groups before treatment,P〈0. 05. After treatment,the blood pressure level of the experimental group was significantly lower than that of the conventional group,P〈0. 05; the total treatment efficiency was 94. 34% in experimental group and 81. 13% in conventional group,P〈0. 05; The blood lipid level after treatment in experimental group was significantly lower than that in conventional group,P〈0. 05. The results showed that the amlodipine atorvastatin calcium tablets were given to hypertension patients with coronary heart disease,and the treatment effect was significant and worthy of adoption.